Search filters

List of works by Björn Dahlöf

A new dawn in cardiovascular protection: total cardiovascular risk: rigorous treatment of risk factors. Introduction

scientific article published in July 2008

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study

scientific article published in November 2004

All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy

scientific article published on 2 July 2010

Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice

scientific article

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

scientific article published in March 2005

Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy

scientific article published in November 2005

Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study.

scientific article published in June 2010

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

scientific article

Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?

scientific article published on January 2007

Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).

scientific article published in September 2009

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

scientific article published in December 2008

Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk

scientific article (publication date: November 2002)

Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study

scientific article

Cardiovascular disease risk factors: epidemiology and risk assessment.

scientific article

Cardiovascular events during differing hypertension therapies in patients with diabetes

scientific article published on June 2010

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.

scientific article

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

scientific article published in March 2005

Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy

scientific article published on 22 August 2005

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

scientific article

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

scientific article

Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study

scientific article published in March 2004

Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

scientific article published in March 2002

Change in pulse pressure/stroke index in response to sustained blood pressure reduction and its impact on left ventricular mass and geometry changes: the life study

scientific article published on 10 April 2008

Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study

scientific article published in July 2002

Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

scientific article

Clinical impact of 'in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study

scientific article published in April 2008

Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study

scientific article published on 24 January 2008

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

scientific article published on 27 October 2009

Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study

scientific article published on 14 June 2012

Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

scientific article published in March 2002

Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).

scientific article published on February 2002

Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial

scientific article published in July 2005

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

scientific article published in February 2005

Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).

scientific article

Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.

scientific article

Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARγ activation

scientific article

Direct stimulation of angiotensin II type 2 receptor enhances spatial memory

scientific article

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy

scientific article

Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study

scientific article published on March 2006

Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study

scientific article

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study

scientific article published in February 2010

Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial

scientific article published on 16 June 2008

Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study

scientific article

Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).

scientific article published in October 2004

Effect of lower on-treatment systolic blood pressure on the risk of atrial fibrillation in hypertensive patients

scientific article published on 08 June 2015

Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy

scientific article published on 19 January 2009

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second [...]

scientific article

Effects of atenolol or losartan on fibrinolysis and von Willebrand factor in hypertensive patients with left ventricular hypertrophy

scientific article published on 13 October 2009

Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study

scientific article published on 7 February 2008

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy

scientific article published in September 2002

Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial

scientific article published in August 2003

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study

scientific article published on 31 August 2009

Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study

scientific article published in October 2006

Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients

scientific article

Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

scientific article published on 19 December 2005

Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint

scientific article published in August 2002

Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study

scientific article published in April 2009

Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction

scientific article

Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients

scientific article published on 10 April 2014

Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy

scientific article published on 26 May 2008

Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe

scientific article published in November 2011

Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients

scientific article published on 15 April 2010

Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study

scientific article

Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

scientific article published on 17 October 2005

Hypertension therapy with beta blocker plus diuretic. "We are at the point of leaving behind an era"

scientific article published in March 2005

Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study

scientific article published on 13 March 2006

Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study).

scientific article published on 13 May 2008

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

scientific article published in July 2010

In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study

scientific article published in June 2010

Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study

scientific article published on 2 December 2008

Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study

scientific article published in November 2009

Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study

scientific article published in June 2002

Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study

scientific article published in June 2010

Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study

scientific article

Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study

scientific article published in July 2008

Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study

scientific article published in June 2008

Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study

scientific article

Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials

scientific article

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study

scientific article published in March 2002

Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study

scientific article

Non-peptide AT2-receptor agonists

scientific article published on 15 December 2010

Pathophysiologic and therapeutic importance of tissue ACE: a consensus report

scientific article

Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study

scientific article published in November 2005

Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment

scientific article

Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs

scientific article

Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

scientific article published on February 2007

Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study

scientific article published in January 2008

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study

scientific article published in January 2009

Preventing stroke in hypertensive patients at risk

scientific article published in July 2008

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

scientific article

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

scientific article

Prevention of stroke in patients with hypertension

scientific article published on 25 May 2007

Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).

scientific article published on October 2010

Prognostic significance of left ventricular mass change during treatment of hypertension

scientific article published in November 2004

Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).

scientific article published on 30 March 2009

Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study

scientific article

Prospects for the prevention of stroke

scientific article published in April 2006

Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).

scientific article published in January 2009

Pulse pressure/stroke index and left ventricular geometry and function: the LIFE Study

scientific article published in April 2003

QRS duration and QT interval predict mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention for Endpoint Reduction in Hypertension Study

scientific article published on 22 March 2004

QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study

scientific article published on 17 August 2009

Racial Differences in Incident Heart Failure During Antihypertensive Therapy ⬇️

scientific article published on 08 February 2011

Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy

scientific article published on 19 February 2014

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line comb

scientific article published in September 2004

Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design

scientific article published in December 2003

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

scientific article published on 17 January 2005

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

scientific article

Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study

scientific article published in April 2006

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

scientific article published in November 2004

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

scientific article

Relation of QT interval and QT dispersion to regression of echocardiographic and electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan Intervention For Endpoint Reduction (LIFE) study

scientific article published in May 2003

Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study

scientific article published in September 2004

Relationship of Sudden Cardiac Death to New-Onset Atrial Fibrillation in Hypertensive Patients With Left Ventricular Hypertrophy ⬇️

scientific article published on February 12, 2013

Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation

scientific article published in July 2010

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

scientific article published on 18 February 2010

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

scientific article published in September 2002

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

scientific article

Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study

scientific article published on 29 April 2010

Sex differences in effects of valsartan administration on cardiovascular outcomes in hypertensive patients: findings from the Jikei Heart Study

scientific article published in June 2010

Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study

scientific article published on 6 December 2004

Surrogate markers for cardiovascular disease: structural markers

scientific article published in June 2004

Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study

scientific article published in October 2013

Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

scientific article

Telmisartan to prevent recurrent stroke and cardiovascular events

scientific article

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

scientific article

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study

scientific article published in January 2003

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study

scientific article published in January 2003

The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study

scientific article (publication date: 6 September 2005)

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study

scientific article published in March 2005

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

scientific article published in March 2004

The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1.

scientific article

Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction

scientific article published on February 2002

Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy

scientific article published on March 2007

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

retracted scientific article published on April 2007

Paulina is supported by:

About Paulina

Help